DRP1 LAtezolizumab | Durwalumab | Serplulimab + CTH 07/26 DRP LDKONSOL.Durwalumab 07/26 MESOTH.1 LNiwolumab+Ipilimumab 07/26 NDRP1 LAfatynib | Ozymertynib 07/26 NDRP1 LAmiwantamab + CTH 07/26 NDRP1 LAmiwantamab+Lazertynib 07/26 NDRP1 LAtezolizumab (unfit) 07/26 NDRP1 LAtezolizumab | Cemiplimab | Niwolumab+Ipilimumab | Pembrolizumab | Durwalumab+Tremelimumab ± CTH 07/26 NDRP1+ LAlektynib | Entrektynib | Kryzotynib | Lorlatynib 07/26 NDRP1+ LEnkorafenib+Binimetynib 07/26 NDRP2+ LAtezolizumab | Niwolumab | Tislelizumab 07/26 NDRP2+ LNintedanib + CTH 07/26 NDRP2+ LOzymertynib 07/26 NDRP2+ LSotorasib | Adagrazyb 07/26 NDRPADIUW.Alektynib 07/26 NDRPADIUW.Atezolizumab 07/26 NDRPADIUW.Ozymertynib 07/26 NDRPADIUW.Pembrolizumab 07/26 NDRPKONSOL.Durwalumab 07/26 NDRPKONSOL.Ozymertynib 07/26 NDRPNEOAD.Niwolumab + CTH 07/26 NDRPOKOŁOOP.Pembrolizumab | Durwalumab | Niwolumab + CTH 07/26